A Phase 1 Study of FIT-CD19-CAR-T Cells in R/R B-ALL

Clinical trial NCT07066397 · RECRUITING

Trial details

NCT number: NCT07066397
Sponsor: TriArm Therapeutics (Taiwan) Limited
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia

Start date: 2025-07-15
Primary completion: 2028-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.